![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories West Pharmaceutical Services has formally announced the end of its Exubera relationship with the product's developers Nektar Therapeutics... Read NPIL and Lilly form 'risk and reward' sharing alliance Nicholas Piramal (NPIL) has signed an innovative drug development deal with Eli Lilly - the second such agreement in a year... Read Charles River accelerates China plans; reports profit jump Charles River Laboratories has reported another profit jump in its Q4 2007 financial results and has also stepped up its China plans as the demand for its preclinical services in the country are said to be "robust"... Read Aceto makes determined pitch for Japanese intermediates Aceto, the US-based distributor and marketer of fine and industrial chemicals, is making a determined pitch for the pharmaceutical intermediates sector in Japan... Read Pharmaceutical outsourcing: people on the move Shasun Chemicals, Patheon, Tepnel Research, ClinPhone and PharmEng have all had people on the move in the world of pharmaceutical outsourcing... Read |
||||||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here | ||||||||||||||||||
|
Related Industry News EU white paper urges competitive spirit in research The EMRC has called for increased funding within the European medical research community to maintain high standards and attract the brightest young researchers... Read FDA starts inspecting stalled Watson facility An end may be in sight to the long-running problems with the Florida manufacturing facility acquired by US brand and generic company Watson Pharmaceuticals with Andrx Corporation in November 2006... Read Pfizer expands in inhaled drugs as Nektar cuts back Pfizer's announcement of plans to create a new €130m inhaled medicines unit at its facility in Amboise, France suggests that the firm is still intent on investing in inhalation technology, despite its disappointment... Read Baxter suspends production of heparin after deaths Baxter International has suspended the production of its blood-thinning drug heparin in multi-dose vials, following the deaths of four patients in the USA who were given the drug in high doses... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||